Live Breaking News & Updates on National organ program
Stay updated with breaking news from National organ program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TransMedics shines with Q1 EPS at $0.35, and sales soared to $96.9 million. Fiscal 2024 revenue outlook raised to $390 million-$400 million. Analysts hail TransMedics' organic growth and strong market position, praising its innovative solutions and promising prospects.